GOLDMAN SACHS & CO. LLC - 10%+ Owner at T2 Biosystems, Inc.

Issuer-level insider activity

Role
10%+ Owner
Issuer ticker
TTOO
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by GOLDMAN SACHS & CO. LLC since 10 Aug 2025

Reported holdings for GOLDMAN SACHS & CO. LLC in T2 Biosystems, Inc.

Form 4 holding 10%+ Owner

T2 Biosystems, Inc.

Security class
Common Stock
Shares / value
4,201,582
Estimated value
$661,749
Report date
20 May 2020
Price
$0.1575
Ownership
Indirect

Transaction history for GOLDMAN SACHS & CO. LLC in T2 Biosystems, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .